Saturday 17 October 2026
Export ENSG’s income statement to Excel — free account
The Ensign Group, Inc.
ENSG Healthcare Medical Care Facilities
The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024. In the quarter to June 2026, revenue grew 17.3%, EPS grew 16.2%, free cash flow grew 12.2% and total debt fell 2.77%, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for five.
176.63
1.48
−0.83%
Follow ENSG
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 16.96% | 16.90% | 16.88% | 16.94% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 8 | 7 | 7 | |
| 7.09% | 7.01% | 6.79% | 6.66% | ||
ROIC |
12.90% | 14.64% | 14.73% | 14.29% | |
Return on Tangible Assets |
16.58% | 16.57% | 16.58% | 16.58% | |
Average Days of Receivables |
44.50 | 45.90 | 45.97 | 46.31 | |
Free Cash Flow per Share |
7.23 | 7.03 | 6.47 | 5.00 | |
Free Cash Flow |
419.09 | 406.10 | 370.71 | 286.85 | |
Capital Expenditures |
(189.34) | (186.10) | (193.56) | (194.56) | |
| Other line items | |||||
Cash ROIC |
14.42% | 13.08% | 12.57% | 10.35% | |
Accounts Receivable Turnover |
8.80 | 8.46 | 8.38 | 8.28 | |
Accounts Payable Turnover |
41.41 | 41.94 | 43.39 | 41.55 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
9.48 | 9.56 | 8.34 | 9.48 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | (0.24) | (0.24) | (0.24) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
5.44% | 5.34% | 5.33% | 5.27% | |
Share Based Compensation of Revenue |
1.02% | 0.98% | 0.95% | 0.94% | |
Interest Coverage |
59.99 | 56.93 | 53.24 | 48.52 | |
Operating CF/Net income |
1.61 | 1.63 | 1.64 | 1.47 | |
Depreciation/Fixed assets |
0.06 | 0.06 | 0.06 | 0.06 | |
Capex/Depreciation |
(1.64) | (1.69) | (1.84) | (1.94) | |
Revenue per Share |
94.67 | 91.29 | 88.26 | 84.16 | |
Operating CF per Share |
10.50 | 10.25 | 9.85 | 8.39 | |
Capex per Share |
(3.27) | (3.22) | (3.38) | (3.39) | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.04 |
Columns are period end dates